Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Proteins & Peptides
Filter     Order     Display # 
Date Item Title
19 Sep 2007 Sinobiomed Updates on Clincial Trial Success for Recombinant Batroxobin (rBat)
19 Sep 2007 Acceleron Pharma Presents Positive Phase 1 Results Demonstrating ACE-011 Increases Markers of Bone Formation
18 Sep 2007 A major pharmaceutical company has taken an exclusive option to BA058, a compound licensed by Ipsen to Radius in 2005
18 Sep 2007 SYGNIS' AX200 shows efficacy in stroke patients
15 Sep 2007 Novartis completes agreement with Bayer Schering related to Betaseron(R) rights and manufacturing
15 Sep 2007 Phase 3 study confirms that liraglutide treatment leads to both glucose and weight reduction with a low risk of hypoglycaemic events
14 Sep 2007 Targanta Initiates Phase 2 Oritavancin Infrequent Dosing Study
13 Sep 2007 FDA Advisory Committees Recommend Continued US Marketing Authorization for Trasylol
13 Sep 2007 Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
12 Sep 2007 Phosphagenics to commence Phase 2 TPM/Insulin cinical trial
12 Sep 2007 Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
12 Sep 2007 Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
11 Sep 2007 Neose Announces Initiation of Phase II Renal Trial of NE-180
11 Sep 2007 Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
11 Sep 2007 Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
11 Sep 2007 First Ever Therapy Targets Optic Nerve Head for Glaucoma
07 Sep 2007 FDA has approved Zealand Pharma's Investigative New Drug application
07 Sep 2007 Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
06 Sep 2007 Pieris validates the use of Anticalins(R) as ophthalmologic biotherapeutics
05 Sep 2007 ThromboGenics Announces Successful Completion of Technology Transfer to
04 Sep 2007 GTC obtains FDA fast track designation for Atryn(R) and permission to submit a rolling BLA
04 Sep 2007 Jerini Regains Commercialization Rights to Icatibant for the Treatment of Hereditary Angioedema in North America
04 Sep 2007 Astellas Announces the Extension of US Regulatory Review for the sNDA of MYCAMINE
01 Sep 2007 BioDiem starts 4 new Monash studies with eye drug BDM-E
01 Sep 2007 Somatuline(R) Depot receives marketing approval in the United States
01 Sep 2007 MediGene: European Approval Procedure for the Six-Months Dosage of Cancer Drug Eligard(R) Successfully Completed
31 Aug 2007 New formulation of multiple sclerosis treatment Rebif (R) approved in European Union
31 Aug 2007 Paion's partner Forest terminates co-development on Desmoteplase
30 Aug 2007 Pharming Presents Positive Results From European Phase III Trial Of Rhucin(R)
30 Aug 2007 King Pharmaceuticals And Palatin Technologies Delay Immediate Plans For Phase 3 Clinical Program With Bremelanotide For Erectile Dysfunction
29 Aug 2007 Orexo's treatment for incontinence/nocturia entering Phase I
29 Aug 2007 OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Thrombin Stand Alone, EVITHROM* Thrombin, Topical (Human), with General Hemostasis in Surgery Indication
29 Aug 2007 Human genome sciences completes enrollment of first Phase 3 Albuferon(R) trial ahead of schedule
28 Aug 2007 Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
28 Aug 2007 Ambrilia Completes Patient Recruitment for the Phase 3 Pivotal Clinical Trial of its Prolonged Release Formulation of Octreotide
28 Aug 2007 Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
27 Aug 2007 IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
27 Aug 2007 AKELA Pharma Inc. enrolls first patient in its Phase IIb CGRP trial
25 Aug 2007 Phylogica enters anti-microbial field
24 Aug 2007 Teijin and Chugai enter an agreement to co-develop Ipsen's anti-diabetic medicine in Japan
24 Aug 2007 ProNAi Therapeutics announces first DNAi(R) mechanism of action studies for PNT2258 oncology drug candidate
23 Aug 2007 Nuvelo re-initiates SONOMA-3 trial of Alfimeprase in patients with catheter occlusion
23 Aug 2007 Med Discovery and DRAXIMAGE establish research collaboration
22 Aug 2007 Sinobiomed Completes Evaluation of Preclinical Safety Studies on World's First Recombinant Human Kallikrein
22 Aug 2007 SemBioSys Updates Apo AI Development Program
21 Aug 2007 Artisan Pharma, Inc. launches Phase 2b trial of ART-123 for the treatment of DIC in sepsis
21 Aug 2007 Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)
21 Aug 2007 Liraglutide improves glucose control and lowers body weight in two phase 3 studies comprising more than 2,000 patients
21 Aug 2007 Wyeth Receives Approval from European Medicines Agency for New BeneFIX Features
20 Aug 2007 Pharming reports positive results in European placebo-controlled trial Of Rhucin(R) in hereditary angioedema
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 451 - 500 of 1318

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics